Benefit of several campaigns like "Jago Grahak Jago" seems to be catching up with the consumers who during the year dared to drag health care giants, banking and insurance major, airlines, Railways, telecom heavy weights and top realtors to various consumer courts for redressal of their grievances.
Leading the way, National Consumer Disputes Redressal Commission (NCDRC), the apex consumer body, in August dealt sternly with pharmaceutical giant Novartis India Ltd for over charging and making exorbitant profit on sale of its non-cancerous drug.
Lal Path Labs, which has a major chain of diagnostic centres, also had to cough up Rs four lakh as damages for wrongly diagnosing a doctor as HIV positive. The lab conducted a DNA test instead of one for HIV virus.
A forum noted that there were rise in number of complaints against the lab and said facts reveal a "shocking state of affairs" as it was "fleecing consumers by false advertisements and using inefficient medical personnel and staff".
In one such case, a nursing home and its two doctors were asked to pay Rs 10 lakh as compensation to a woman for leaving a piece of sponge in her abdomen during an operation in 2012 resulting in formation of 1.5 litre pus in her body.
Real-estate firms were rapped by consumer fora which in several cases held that these firms were taking money on false temptation and misrepresentation and also failing to provide property and making profits at the expense of others.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
